Post by AveThera

From Vision to Reality: AveThera Arrives in Braunschweig We are proud to share an exciting milestone for AveThera. AveThera has acquired the Fraunhofer ITEM site in Braunschweig, marking an important step in our mission to expand advanced biopharmaceutical manufacturing in Europe. Our first facility in Hennigsdorf will provide capabilities for biologics drug substance and drug product manufacturing, alongside quality control testing and quality assurance oversight. The newly acquired Braunschweig site will complement this infrastructure with additional biologics drug substance and drug product development and manufacturing capabilities, as well as expanded quality control laboratories and quality assurance functions. Together, these two sites position AveThera to scale into a multi-product biologics enterprise over the next 3–4 years, enabling us to support patients across Germany, Europe, and globally. We are excited to begin this new chapter on the Braunschweig campus and look forward to collaborating with the local scientific community, partners, and stakeholders as we build the future of biologics manufacturing. #AveThera #Biopharma #Biologics #Braunschweig #Biomanufacturing